Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
The New England Journal of Medicine
|
August 26, 2021
Psilocybin for Depression. Reply
Robin Carhart-Harris, Allan Blemings, David J Nutt
Journal of Vascular Surgery
|
June 18, 2013
Randomized clinical trial comparing endovenous laser ablation and stripping of the great saphenous vein with clinical and duplex outcome after 5 years
Lars Rasmussen, Martin Lawaetz, Lars Bjoern, et al.
Journal of Vascular Surgery
|
June 30, 2007
Randomized trial comparing endovenous laser ablation of the great saphenous vein with high ligation and stripping in patients with varicose veins: short-term results
Lars H Rasmussen, Lars Bjoern, Martin Lawaetz, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders
|
March 20, 2016
Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy, and surgical stripping for great saphenous varicose veins with 3-year follow-up
Lars Rasmussen, Martin Lawaetz, Julie Serup, et al.
International Angiology : a Journal of the International Union of Angiology
|
February 21, 2017
Comparison of endovenous ablation techniques, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Extended 5-year follow-up of a RCT
Martin Lawaetz, Julie Serup, Birgit Lawaetz, et al.
Elife
|
March 2, 2021
Self-blinding citizen science to explore psychedelic microdosing
Balázs Szigeti, Laura Kartner, Allan Blemings, et al.
Critical Care (London, England)
|
August 16, 2017
Selepressin, a novel selective vasopressin V<sub>1A</sub> agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients
James A Russell, Jean-Louis Vincent, Anne Louise Kjølbye, et al.
The New England Journal of Medicine
|
April 14, 2021
Trial of Psilocybin versus Escitalopram for Depression
Robin Carhart-Harris, Bruna Giribaldi, Rosalind Watts, et al.
The Journal of Allergy and Clinical Immunology
|
November 13, 2025
Targeting IL-22RA1 with temtokibart: A novel approach in atopic dermatitis: Phase 2a monotherapy study results
Diamant Thaçi, Vivian Laquer, Charles Lynde, et al.
JACC. Cardiooncology
|
August 16, 2021
Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer: The PRONOUNCE Trial Study Design
Chiara Melloni, Susan F Slovin, Allan Blemings, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
The New England Journal of Medicine
|
August 26, 2021
Psilocybin for Depression. Reply
Robin Carhart-Harris, Allan Blemings, David J Nutt
Journal of Vascular Surgery
|
June 18, 2013
Randomized clinical trial comparing endovenous laser ablation and stripping of the great saphenous vein with clinical and duplex outcome after 5 years
Lars Rasmussen, Martin Lawaetz, Lars Bjoern, et al.
Journal of Vascular Surgery
|
June 30, 2007
Randomized trial comparing endovenous laser ablation of the great saphenous vein with high ligation and stripping in patients with varicose veins: short-term results
Lars H Rasmussen, Lars Bjoern, Martin Lawaetz, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders
|
March 20, 2016
Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy, and surgical stripping for great saphenous varicose veins with 3-year follow-up
Lars Rasmussen, Martin Lawaetz, Julie Serup, et al.
International Angiology : a Journal of the International Union of Angiology
|
February 21, 2017
Comparison of endovenous ablation techniques, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Extended 5-year follow-up of a RCT
Martin Lawaetz, Julie Serup, Birgit Lawaetz, et al.
Elife
|
March 2, 2021
Self-blinding citizen science to explore psychedelic microdosing
Balázs Szigeti, Laura Kartner, Allan Blemings, et al.
Critical Care (London, England)
|
August 16, 2017
Selepressin, a novel selective vasopressin V<sub>1A</sub> agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients
James A Russell, Jean-Louis Vincent, Anne Louise Kjølbye, et al.
The New England Journal of Medicine
|
April 14, 2021
Trial of Psilocybin versus Escitalopram for Depression
Robin Carhart-Harris, Bruna Giribaldi, Rosalind Watts, et al.
The Journal of Allergy and Clinical Immunology
|
November 13, 2025
Targeting IL-22RA1 with temtokibart: A novel approach in atopic dermatitis: Phase 2a monotherapy study results
Diamant Thaçi, Vivian Laquer, Charles Lynde, et al.
JACC. Cardiooncology
|
August 16, 2021
Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer: The PRONOUNCE Trial Study Design
Chiara Melloni, Susan F Slovin, Allan Blemings, et al.
Page
of 2